CFO David O’Toole’s steady buying spree signals confidence as Avita Medical’s stock reels from a 32% year‑to‑date drop.
Avita Medical CFO’s recent 2,000‑share purchase signals confidence and may signal undervaluation amid a steep 32% YTD drop.
3 minutes to read


